PRAX vs SYRE: stock comparison and AI forecast
Praxis Precision Medicines, Inc. (PRAX) and Spyre Therapeutics, Inc. (SYRE) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
PRAX Praxis Precision Medicines, Inc.
- Price
- $273.99 -18.8% · 6M
- Market Cap
- $7.65B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
SYRE Spyre Therapeutics, Inc.
- Market Cap
- $8.42B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- SYRE is 1.1 times larger than PRAX by market capitalization ($8.42B against $7.65B).
- SYRE carries 0.07 times debt per unit of equity, against 0.04 times for PRAX.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | PRAX | SYRE |
|---|---|---|
| Market Cap | $7.65B | $8.42B |
| P/B Ratio | 5.70x | 7.65x |
| EPS | $-12.95 | $-2.33 |
| Book Value/Share | $48.03 | $12.49 |
| FCF/Share | $-10.94 | – |
Profitability & Margins
| Metric | PRAX | SYRE |
|---|---|---|
| ROE | -25.3% | -16.2% |
| ROA | -24.4% | -15.2% |
| ROIC | -28.2% | -18.1% |
| Tax Rate | – | 0.0% |
Financial Health
| Metric | PRAX | SYRE |
|---|---|---|
| Current Ratio | 15.73x | 18.53x |
| D/E Ratio | 0.04x | 0.07x |
| Financial Leverage | 1.04x | 1.07x |
| Working Capital | $723M | $1.11B |
Cash Flow
| Metric | PRAX | SYRE |
|---|---|---|
| Operating Cash Flow | -$305M | -$209M |
| Free Cash Flow | -$305M | – |
| Capital Spending | -$310K | – |
Income Statement
| Metric | PRAX | SYRE |
|---|---|---|
| Operating Income | -$378M | -$201M |
| Net Income | -$339M | -$179M |
| R&D Expense | $291M | $216M |
Dividend & Shareholder Information
| Metric | PRAX | SYRE |
|---|---|---|
| Shares Outstanding | 28M | 88M |
PRAX vs SYRE: stock comparison and AI forecast
Which is bigger, PRAX or SYRE?
SYRE is 1.1 times larger than PRAX by market capitalization ($8.42B against $7.65B).
Which one does Intratio's AI model rank higher, PRAX or SYRE?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.